Efforts are underway to match breast cancer patients with new clinical trials, potentially increasing access to treatment options. The use of new technologies, such as ai platforms and blood tests, may aid in this process by tracking cancer changes and identifying suitable trials for patients. However, the effectiveness of these approaches, particularly ai-powered trial matching, is being discussed and evaluated.